[go: up one dir, main page]

AU2015904022A0 - Implants for the Treatment of Diseases and Disorders - Google Patents

Implants for the Treatment of Diseases and Disorders

Info

Publication number
AU2015904022A0
AU2015904022A0 AU2015904022A AU2015904022A AU2015904022A0 AU 2015904022 A0 AU2015904022 A0 AU 2015904022A0 AU 2015904022 A AU2015904022 A AU 2015904022A AU 2015904022 A AU2015904022 A AU 2015904022A AU 2015904022 A0 AU2015904022 A0 AU 2015904022A0
Authority
AU
Australia
Prior art keywords
implants
disorders
diseases
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2015904022A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Palmaya Pty Ltd
Original Assignee
Palmaya Pty Ltd
Filing date
Publication date
Application filed by Palmaya Pty Ltd filed Critical Palmaya Pty Ltd
Publication of AU2015904022A0 publication Critical patent/AU2015904022A0/en
Abandoned legal-status Critical Current

Links

AU2015904022A 2015-10-02 Implants for the Treatment of Diseases and Disorders Abandoned AU2015904022A0 (en)

Publications (1)

Publication Number Publication Date
AU2015904022A0 true AU2015904022A0 (en) 2015-10-22

Family

ID=

Similar Documents

Publication Publication Date Title
IL298690B1 (en) Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders
EP3177732A4 (en) Compositions and methods for the treatment of ophthalmic diseases and conditions
EP3122878A4 (en) Mrna therapy for the treatment of ocular diseases
EP3259017A4 (en) Nerve stimulation for treatment of diseases and disorders
EP3596063A4 (en) Pyrimidinyl-pyridyloxy-naphthyl compounds and methods of treating ire1-related diseases and disorders
EP3268007A4 (en) Compositions and therapeutic methods for the treatment of complement-associated diseases
EP4591936A3 (en) Treatment of respiratory diseases
ZA201906213B (en) Compounds and methods for the treatment of parasitic diseases
EP3630065A4 (en) Treatment of depressive disorders
EP3258930A4 (en) Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders
EP3119387A4 (en) Compositions for the treatment of dermatological diseases and disorders
EP3154637A4 (en) Treatment of virus-based diseases of the skin
EP3107534A4 (en) Compositions and methods for the treatment of neurodegenerative diseases
EP3283457A4 (en) Compounds and methods for the treatment of neurodegenerative diseases
SMT202100070T1 (en) Complex and compositions for the treatment of ophthalmic and dermatological diseases
EP3507277B8 (en) Hydroxynorketamine derivatives for the treatment of disorders
EP3129054A4 (en) Methods and compositions for the treatment of ocular diseases and disorders
EP3500591A4 (en) Compositions and methods for treatment of bone associated diseases
HK40092382A (en) Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders
HK40093809A (en) Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders
HK40109502A (en) Anti-renalase antibodies for the treatment and prevention of diseases and disorders
HK40121582A (en) Methods and compositions for treatment of epileptic disorders
HK40092381A (en) Compositions and methods for inhibiting masp-3 for treatment of various diseases and disorders
GB201604359D0 (en) Treatment of tissue disorders
HK40101362A (en) Azolopyrimidine for the treatment of cancer-related disorders